Retagen’s innovative solutions target challenges like disparate cell type approaches, suboptimal tissue health, efficient commercial scaling, humanized tissue development, and reduced adoption barriers. These efforts aim to revolutionise bioengineering, enhancing research impact and real-world applications through easy-to-adopt and shippable tissues.